X0306 4 2016-01-28 0 0001479290 Revance Therapeutics, Inc. RVNC 0001225755 SILVERNAIL LAUREN P C/O REVANCE THERAPEUTICS, INC. 7555 GATEWAY BOULEVARD NEWARK CA 94560 0 1 0 0 CFO, CBO & Secretary Common Stock 2016-01-28 4 F 0 1063 20.30 D 21695 D Represents the number of shares withheld by and surrendered to the Issuer on January 28, 2016, to satisfy tax withholding obligations that arose in connection with the first annual installment of vesting of the Restricted Stock Award ("RSA") for 7,290 shares. The RSA vests in three equal annual installments from January 28, 2015, subject to Mrs. Silvernail's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) on each vesting date. /s/ Gordon Ho, Attorney-in-Fact 2016-02-01